Regenerative Medical Technology (RMTG) Other Operating Expenses (2018 - 2026)

Regenerative Medical Technology's Other Operating Expenses history runs 9 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 88.31% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 53.39% YoY), while the FY2025 annual figure was $2.6 million, up 31.61% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $1.1 million, up from $696451.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $2.7 million in Q4 2022, with the low at $318940.0 in Q3 2022.
• The 5-year median for Other Operating Expenses is $486454.0 (2024), against an average of $657665.4.
• Peak annual rise in Other Operating Expenses reached 450.15% in 2022, while the deepest fall reached 96.47% in 2022.
• Regenerative Medical Technology's Other Operating Expenses stood at $2.7 million in 2022, then slumped by 86.27% to $374861.0 in 2023, then climbed by 29.77% to $486454.0 in 2024, then soared by 43.17% to $696451.0 in 2025, then soared by 52.33% to $1.1 million in 2026.
• Business Quant data shows RMTG's Other Operating Expenses at $1.1 million in Q1 2026, $696451.0 in Q4 2025, and $669622.0 in Q3 2025.